Management of fistula disease

Inflammatory Bowel Diseases

Volumn 4, Issue 4, 1998, Pages 302-307

  Present, Daniel H ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT;

CLINICAL TRIAL; COLON DISEASE; CONFERENCE PAPER; CROHN DISEASE; FEMALE; HUMAN; INTESTINE FISTULA; MALE; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; COLONIC DISEASES; CROHN DISEASE; FEMALE; HUMANS; INTESTINAL FISTULA; MALE; TREATMENT OUTCOME;

EID: 0032200663     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780040409     Document Type: Conference Paper

References (21)

1. Allan A, Keighley RB. Management of perianal disease. World J Surg 1988;12:198-202.
2. Givel JC, Hawker P, Allan R, et al. Entero-enteric fistula complicating Crohn's disease. J Clin Gastroenterol 1983;5:321-3.
3. Williams JG, Hughes LE. Abdominal perineal resection for severe perianal Crohn's disease. Dis Colon Rectum 1990;33:402-7.
4. Brady CE, Cooley B, Davis JC. Healing of severe perineal and cutaneous Crohn's disease with hyperbaric oxygenation. Gastroenterology 1989;97:756-60.
5. Ursing B, Alm T, Barany F, et al. A comparative study in metronidazole and sulfasalazine for active Crohn's disease. Gastroenterology 1982;83:550-62.
6. Sutherland L, Singleton J, Sessions J, et al. Double blind placebo controlled trial of metronidazole in Crohn's disease. Gut 1991;32: 1071-5.
7. Bernstein LH, Frank MS, Grant LJ, Boley S. Healing of perineal Crohn's disease with metronidazole. Gastroenterology 1980;79: 357-65.
8. Brandt LJ, Bernstein LH, Boley S, Frank MS. Metronidazole therapy for perineal Crohn's disease. A followup study. Gastroenterology 1982;83:383-7.
9. Babb R. The use of metronidazole in Crohn's disease. J Clin Gastroenterol 1988;10:479-81.
10. Present DH, Korelitz BI, Wisch N, et al. Treatment of Crohn's disease with 6-mercaptopurine. A long term randomized double blind study. N Engl J Med 1980;302:981-7.
11. Korelitz BI, Present DH. Favorable response of 6-mercaptopurine on fistula of Crohn's disease. Dig Dis Sci 1985;30:58-64.
12. O'Brien JJ, Bayless TM, Bayless JA. Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease. Gastroenterology 1991;101:39-46.
13. Pichney LS, Fantry GT, Graham SM. Gastrocolic and duodeno-colic fistulas in Crohn's disease. J Clin Gastroenterol 1992;15: 205-11.
14. Greenstein AJ, Present DH, Sachar DB, et al. Gastric fistulas in Crohn's disease. Dis Colon Rectum 1989;32:888-92.
15. Wheeler SC, Marion JF, Present DH. Medical therapy, not surgery, is the appropriate first line of treatment for Crohn's entero-vessical fistula. Gastroenterology 1998;114:A1113.
16. Kozarek RA, Patterson DJ, Gelfand MD, et al. Methotrexate induced clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989;110:353-6.
17. Feagan VG, Rochon J, Fedorak RN, et al. Methotrexate for the treatment of Crohn's disease. N Engl J Med 1995;332:292-7.
18. Muhadevan U, Marion J, Present DH. The place of methotrexate in the treatment of refractory Crohn's disease. Gastroenterology 1997;112:A1031.
19. Hanauer SB, Smith MD. Rapid closure of Crohn's disease fistula with continuous intravenous cyclosporine. Am J Gastroenterol 1993;88:646-9.
20. Present DH, Lichtiger S. Efficacy of cyclosporine in the treatment of fistula of Crohn's disease. Dig Dis Sci 1994;39:374-80.
21. Present DH, Mayer L, van Deventer SVH, et al. Anti TNF alpha chimeric antibody (cA2) is effective in the treatment of the fistula of Crohn's disease. Am J Gastroenterol 1997;92:A648:p1746.